GoodRx: Great Value For Patient Investors (Upgrade)

Group 1 - Value stocks have lost favor as investors focus on high-growth stocks, particularly those linked to the AI industry [1] - There is a notable decline in valuation multiples due to concerns about a potential U.S. recession [1] - Gary Alexander has extensive experience in technology sectors, both on Wall Street and in Silicon Valley, influencing current industry themes [1]